Videos
Managing Insomnia: Addressing Shortcomings in OTC Medications
Panelists review suboptimal over-the-counter medications that patients may use to manage insomnia.
Understanding Cognitive Post-Acute Sequelae of COVID-19: Joanna Hellmuth, MD, MHS
January 24th 2022The cognitive neurologist at the University of California San Francisco provided insight on how she’s taken a cognitive neurology approach to the COVID-19 pandemic, and how her background in HIV influenced her recent research. [WATCH TIME: 5 minutes]
Transitioning From Childhood to Adulthood With Migraine: Christina Szperka, MD, MSCE
January 23rd 2022The director of the Pediatric Headache Program at CHOP commented on the need to treat migraine early to avoid secondary effects and decrease the odds of long-term disability. [WATCH TIME: 3 minutes]
Challenges in Treating Pediatric Migraine: Christina Szperka, MD, MSCE
January 21st 2022Discussing the need to identify an effective first-line treatment, the director of the Pediatric Headache Program at CHOP further discussed treatment adherence in this patient population. [WATCH TIME: 5 minutes]
Use of Seizure Apps During the Pandemic, Need for Data: Jessica Fesler, MD, MEd
January 21st 2022The staff epileptologist at Cleveland Clinic’s Epilepsy Center gave her expert opinion on whether seizure app usage has increased during the COVID-19 pandemic and why there remains a need for further data collections. [WATCH TIME: 2 minutes]
Treating Migraine in Children Versus Adults: Christina Szperka, MD, MSCE
January 20th 2022The director of the Pediatric Headache Program at CHOP broke down the treatment of pediatric migraine into 3 different pieces: lifestyle habits, acute treatment, and preventive therapies. [WATCH TIME: 5 minutes]
Future Research for Blood Biomarkers in Patients Hospitalized With COVID-19: Jennifer Frontera, MD
January 18th 2022The professor of neurology at NYU Langone Grossman School of Medicine discussed future research for neurological complications in patients hospitalized with COVID-19 infection. [WATCH TIME: 4 minutes]
Advantages and Potential of MR Fingerprinting in Epilepsy, Neurology: Irene Wang, PhD
January 18th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center discussed opportunities for MR fingerprinting to expand, both in the epilepsy field and in general neurology. [WATCH TIME 3 minutes]
Considering Cognitive Behavioral Therapy for Insomnia
Expert perspectives on the benefits of and limitations to cognitive behavioral therapy for insomnia.
Directions for Future Research on COVID-Disorders of Consciousness: David Fischer, MD
January 16th 2022The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital highlighted areas for future research to better understand disorders of consciousness associated with COVID-19. [WATCH TIME: 2 minutes]
Improving Recognition, Diagnosis of Psychogenic Nonepileptic Seizures: Becky Tilahun, PhD
January 14th 2022The clinical psychologist at Cleveland Clinic provided insight on the tricky nature of diagnosing a patient with nonepileptic seizures and the difficult conversations that can ensue. [WATCH TIME: 3 minutes]
The Changing Landscape of Preventative Migraine Treatments
A panel of expert neurologists shares advice for community neurologists on preventive migraine treatment and exciting therapies to look forward to.
Disorders of Consciousness and COVID-19: David Fischer, MD
January 14th 2022The neurocritical care fellow at Massachusetts General Hospital and Brigham and Women’s Hospital discussed findings from a recent study that evaluated patients with COVID-19 and disorders of consciousness. [WATCH TIME: 3 minutes]
Using Radiomics-Based MR Fingerprinting to Detect Focal Cortical Dysplasia: Irene Wang, PhD
January 13th 2022The research director and staff scientist at Cleveland Clinic’s Epilepsy Center provided insight on her study presented at AES 2021, which showed that MR fingerprinting can differentiate focal cortical dysplasia from healthy tissue. [WATCH TIME: 4 minutes]
Using SAGE to Detect Mild Cognitive Impairment Earlier: Douglas Scharre, MD
January 13th 2022Outlining the findings from a recent study comparing SAGE to the Mini-Mental State Examination, the director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center stressed the importance of identifying patients at-risk for dementia early on. [WATCH TIME: 6 minutes]
SAGE and BrainTest for Cognitive Assessment and Clinical Trial Enrollment: Douglas Scharre, MD
January 12th 2022The director of the Division of Cognitive and Memory Disorders at the Ohio State Wexner Medical Center discussed benefits of both the pen-and-paper and digital assessments. [WATCH TIME: 7 minutes]
Clinical Experience as a Factor in the Inconsistencies of Migraine Care: Anne-Maree Kelly, MD
January 12th 2022The director of the Joseph Epstein Center for Emergency Medicine Research discussed whether years of experience causes variation in the way migraine is diagnosed and treated in an emergency department setting. [WATCH TIME: 2 minutes]
